What To Expect From Transdermal Verapamil 15% Gel
It is important to understand that there are no "quick fix" treatments for Dupuytren's disease. This is because remodeling tissue is a slow process. Patients should expect to use Transdermal Verapamil 15% Gel for 6 to 12 months to complete their treatment. Patients with a family history or who have an early onset of the condition are more likely to have a recurrence and may need additional treatment. Patients who are experiencing pain or discomfort typically see this as the first symptom to be significantly improved, usually within 90 days. Also by 90 days, patients typically can feel a reduction or softening of the nodules or cords. Once they have started to remodel, the contracture and dermal pits begin to decrease.
What Happens If I Am Not Getting Better?
As with any medication, Transdermal Verapamil 15% Gel will not help everyone; however, PDLabs wants to make every effort to maximize the results patients receive. Patients that are not responding tend to fall into one of two categories. First are patients that do not improve at all and patients that have responded but seem to have reached a plateau and no longer improving. All patients are started on a twice a day regimen since this is effective for the majority of patients. If you are not responding at this dose, a PDLabs pharmacist will contact your doctor to discuss alternative doses that have proven effective in other patients that might be appropriate for you.
Side effects for patients treating Dupuytren's disease have been very rare. Due to the highly tolerant nature of the skin on the hands, the skin irritation seen in Peyronie's disease patients has not been seen. Since verapamil is a medication used to reduce blood pressure when it is taken orally, patients should report any dizziness, sudden rapid heart beat, or unusual irregular or rapid heart beat to PDLabs and/or their doctor.